Biotech Firm Enjoys Exploding Sales Of Blood Cancer Treatment

Biotech Firm Enjoys Exploding Sales Of Blood Cancer Treatment CNNMoney.com -
USA Cancers of the blood and bone marrow are difficult to treat. But Celgene
(NASDAQ:CELG) says its research and development team is making progress.

http://money.cnn.com/news/newsfeeds/articles/newstex/IBD-0001-19566796.htm

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://money.cnn.com/news/newsfeeds/a
rticles/newstex/IBD-0001-19566796.htm


Biotech News
AZhttp, Inc.
Biotechnology Marketing